Literature DB >> 15888737

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer.

E J D Van Cutsem1, V V Kataja.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15888737     DOI: 10.1093/annonc/mdi808

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  Surveillance of patients following surgery with curative intent for colorectal cancer.

Authors:  Steven Gan; Katherine Wilson; Paul Hollington
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

2.  Colon Cancer Staging in Vulnerable Older Adults: Adherence to National Guidelines and Impact on Survival.

Authors:  T B Leal; T Holden; L Cavalcante; G O Allen; J R Schumacher; M A Smith; J M Weiss; H B Neuman; N K LoConte
Journal:  Ann Hematol Oncol       Date:  2014

3.  Evaluation of a rabbit rectal VX2 carcinoma model using computed tomography and magnetic resonance imaging.

Authors:  Xin-Mei Liang; Guang-Yu Tang; Ying-Sheng Cheng; Bi Zhou
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

Review 4.  Detection of recurrent rectal cancer with CT, MRI and PET/CT.

Authors:  O Schaefer; M Langer
Journal:  Eur Radiol       Date:  2007-04-03       Impact factor: 7.034

Review 5.  Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer.

Authors:  S Eggington; P Tappenden; A Pandor; S Paisley; M Saunders; M Seymour; P Sutcliffe; J Chilcott
Journal:  Br J Cancer       Date:  2006-10-10       Impact factor: 7.640

6.  Low molecular weight procyanidins from grape seeds enhance the impact of 5-Fluorouracil chemotherapy on Caco-2 human colon cancer cells.

Authors:  Ker Y Cheah; Gordon S Howarth; Keren A Bindon; James A Kennedy; Susan E P Bastian
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.